Home Cart Sign in  
Chemical Structure| 27876-94-4 Chemical Structure| 27876-94-4

Structure of Crocetin
CAS No.: 27876-94-4

Chemical Structure| 27876-94-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Crocetin, a saffron derivative, is an inhibitor of human lactate dehydrogenase 5 in the antiglycolytic approach against cancer.

Synonyms: Transcrocetin; NSC 407300; trans-Crocetin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Crocetin

CAS No. :27876-94-4
Formula : C20H24O4
M.W : 328.40
SMILES Code : O=C(O)/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C(O)=O
Synonyms :
Transcrocetin; NSC 407300; trans-Crocetin
MDL No. :MFCD00017359
InChI Key :PANKHBYNKQNAHN-MQQNZMFNSA-N
Pubchem ID :5281232

Safety of Crocetin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary neuronal cells 25 µM 12 hours Induced autophagy, increased LC3B-II levels, reduced SQSTM1 expression PMC8632093
N9 microglial cells 3.12 to 50 µM 12 hours Induced autophagy, increased LC3B-II levels, reduced SQSTM1 expression PMC8632093

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Wild-type mice Oral gavage 5, 10 and 20 mg/kg Once daily for 30 days Induced autophagy, increased expression of autophagy-related protein markers PMC8632093

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01278277 Retinal Degeneration ... More >> Genetic Disease Single-Gene Defects Macular Dystrophy Less << Phase 1 Phase 2 Active, not recruiting December 2017 Italy ... More >> Policlinico A. Gemelli Rome, Italy, 00168 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.05mL

0.61mL

0.30mL

15.23mL

3.05mL

1.52mL

30.45mL

6.09mL

3.05mL

References

 

Historical Records

Categories